Fredun Pharmaceuticals Allots 40,000 Equity Shares to Promoter Upon Warrant Conversion

Fredun Pharmaceuticals Allots 40,000 Equity Shares to Promoter Upon Warrant Conversion

Fredun Pharmaceuticals Allots 40,000 Equity Shares to Promoter Upon Warrant Conversion​

Fredun Pharmaceuticals Ltd has allotted 40,000 Equity Shares to a Promoter following the conversion of convertible warrants. The allotment was formalized by the Board of Directors during a meeting held on April 09, 2026.

The transaction followed the approval of Shareholders in an Extra-Ordinary General Meeting on October 22, 2025, where convertible warrants were allotted on a preferential basis to Promoters on December 29, 2025. The warrant holders have since paid the balance consideration, totaling Rs. 3,75,00,000/-, and exercised their right to convert 40,000 warrants into an equivalent number of Equity Shares.

The Board of Directors meeting on April 09, 2026, resulted in the allotment of 40,000 Equity Shares, each with a face value of Rs. 10/-.

The details of the allotment are as follows:

Sr. No.Name of AllotteeCategory of InvestorTotal Warrants Allotted (A)Equity Shares Allotted (B)Warrants Outstanding (A) minus (B) = (C)
1Mrs. Daulat Nariman MedhoraPromoter40,00040,000NIL
TOTAL40,00040,000NIL

The equity shares allotted shall rank pari passu with the company's existing Equity Shares in all respects and will be made in dematerialized form.

The information regarding the issuance of securities pertains to a preferential issue under Chapter V of the SEBI ICDR Regulations 2018 and other applicable law. The total allotment of 40,000 fully paid-up Equity Shares was completed at an issue price of ₹ 1250/- each, including a premium of ₹ 1240/- each. This followed the receipt of a balance amount at the rate of ₹ 937.50/- per warrant for the conversion, aggregating to ₹ 3,75,00,000/-.

The warrant holders had originally been allotted warrants on December 29, 2025, giving the right to subscribe to one Equity Share per warrant upon receipt of an amount at the rate of Rs. 312.50/- per warrant (which represented 25% of the issue price per warrant).

The total number of investors involved in this transaction was one.

Stock Price Movement​

At the close of trade today, Fredun Pharmaceuticals Ltd settled at ₹1834.75, ticking up for investors by 4.40%. The shares fluctuated all day, marking a range between a low of ₹1724.00 and a high of ₹1846.00.

Source:​

 

Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.

The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.

Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.

Last edited by a moderator:
Back
Top